NCT01893775View on ClinicalTrials.gov

Antibody Treatment for Advanced Celiac Disease

PHASE1CompletedINTERVENTIONAL

Enrollment

5

Participants

Timeline

Start Date

June 12, 2013

Primary Completion Date

December 20, 2019

Study Completion Date

December 20, 2019

Conditions

Celiac DiseaseCeliac SprueGluten EnteropathyGluten-Sensitive Enteropathy

Interventions

BIOLOGICAL

Hu-Mik- Beta-1

Hu-Mik-Beta-1 every 3 weeks for a total of 3 doses (given on day 1, week 3 and week 6)

Trial Locations (1)

55905

Mayo Clinic, Rochester, Rochester

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Mayo Clinic

OTHER

lead

National Cancer Institute (NCI)

NIH